These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays. Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195 [TBL] [Abstract][Full Text] [Related]
3. High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020. Zhang S; Ma P; Orzechowski M; Lemmer A; Rzasa K; Bagnall J; Barkho S; Chen M; He L; Neitupski R; Tran V; Ackerman R; Gath E; Bond A; Frongillo G; Cleland T; Golas A; Gaca A; Fitzgerald M; Kelly K; Hazegh K; Dumont L; Hoffman C; Homer M; Marks P; Woolley A; Wong S; Gomez J; Livny J; Hung D mBio; 2023 Apr; 14(2):e0352322. PubMed ID: 36786604 [TBL] [Abstract][Full Text] [Related]
4. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum. Lu L; Chu AW; Zhang RR; Chan WM; Ip JD; Tsoi HW; Chen LL; Cai JP; Lung DC; Tam AR; Yau YS; Kwan MY; To WK; Tsang OT; Lee LL; Yi H; Ip TC; Poon RW; Siu GK; Mok BW; Cheng VC; Chan KH; Yuen KY; Hung IF; To KK EBioMedicine; 2021 Sep; 71():103544. PubMed ID: 34419925 [TBL] [Abstract][Full Text] [Related]
5. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers. Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679 [TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls. Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009 [TBL] [Abstract][Full Text] [Related]
13. Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: A transversal surrogate in vitro study performed in Quito-Ecuador. Villacrés-Granda B; Paz E; Burbano MJ; Villacrés-Granda I; Armijos D; Aguirre M J Med Virol; 2022 Sep; 94(9):4246-4252. PubMed ID: 35585654 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity. McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155 [TBL] [Abstract][Full Text] [Related]
15. Isotyping and quantitation of the humoral immune response to SARS-CoV-2. Goyins KA; Yu JJ; Papp SB; Beddard R; Murthy AK; Chambers JP; Arulanandam BP Exp Biol Med (Maywood); 2022 Jun; 247(12):1055-1060. PubMed ID: 35369776 [TBL] [Abstract][Full Text] [Related]
16. Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant. Springer DN; Perkmann T; Jani CM; Mucher P; Prüger K; Marculescu R; Reuberger E; Camp JV; Graninger M; Borsodi C; Deutsch J; Lammel O; Aberle SW; Puchhammer-Stöckl E; Haslacher H; Höltl E; Aberle JH; Stiasny K; Weseslindtner L Microbiol Spectr; 2022 Oct; 10(5):e0212922. PubMed ID: 36005839 [TBL] [Abstract][Full Text] [Related]